LONDON, June 30 (Reuters): A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.    The Medicines and Healthcare Products Regulatory Agency (MHRA) took its decision on what is known as the COPCOV trial after hydroxychloroquine was found in another British trial to have no benefit as a treatment for patients already infected with

NEW DELHI, MAY 27 (IANS): One of the pioneers to initiate hydroxychloroquine (HCQ) therapy in COVID-19 positive patients, Dr Sudhir Bhandari, Principal and Controller, Sawai Madho Singh Medical College Hospitals, Jaipur has slammed the decision of the World Health Organisation (WHO) to temporarily put on hold the HCQ trial.   Sharing his views with IANS, Bhandari said the WHO decision has drawn severe censure and flak from the medical fraternity across India.   Th